Barclays PLC Buys 14,647 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Barclays PLC boosted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 111.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 27,737 shares of the company’s stock after purchasing an additional 14,647 shares during the period. Barclays PLC’s holdings in USANA Health Sciences were worth $1,052,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in USNA. Bank of New York Mellon Corp increased its stake in USANA Health Sciences by 5.6% during the second quarter. Bank of New York Mellon Corp now owns 97,375 shares of the company’s stock worth $4,405,000 after acquiring an additional 5,205 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of USANA Health Sciences by 7.1% during the 2nd quarter. Rhumbline Advisers now owns 36,486 shares of the company’s stock worth $1,651,000 after acquiring an additional 2,425 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after acquiring an additional 191,289 shares during the period. TD Asset Management Inc grew its position in USANA Health Sciences by 26.4% in the 2nd quarter. TD Asset Management Inc now owns 11,500 shares of the company’s stock valued at $520,000 after acquiring an additional 2,400 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in USANA Health Sciences by 12.3% in the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock worth $7,229,000 after purchasing an additional 17,460 shares during the period. 54.25% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

USANA Health Sciences Stock Performance

Shares of USNA opened at $35.29 on Tuesday. The stock has a market capitalization of $672.63 million, a PE ratio of 12.47, a PEG ratio of 1.25 and a beta of 0.89. The company has a 50 day moving average price of $37.88 and a 200-day moving average price of $39.84. USANA Health Sciences, Inc. has a fifty-two week low of $31.44 and a fifty-two week high of $54.81.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the prior year, the business earned $0.59 earnings per share. Equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday. DA Davidson upgraded USANA Health Sciences to a “hold” rating in a report on Friday, December 20th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.